Lifecore Biomedical, Inc. (LFCR) Earnings History
Annual and quarterly earnings data from 1996 to 2025
Loading earnings history...
LFCR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LFCR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 31.3% | -13.4% | -30.0% |
| 2024 | 32.6% | -6.9% | 9.4% |
| 2023 | 27.1% | -21.1% | -96.4% |
| 2022 | 35.1% | -10.6% | -104.9% |
| 2021 | 38.6% | -8.7% | -32.0% |
Download Data
Export LFCR earnings history in CSV or JSON format
Free sign-in required to download data
Lifecore Biomedical, Inc. (LFCR) Earnings Overview
As of May 8, 2026, Lifecore Biomedical, Inc. (LFCR) reported trailing twelve-month net income of -$34M, reflecting -484.8% year-over-year growth. The company earned $-0.91 per diluted share over the past four quarters, with a net profit margin of -30.0%.
Looking at the long-term picture, LFCR's historical earnings data spans multiple years. The company achieved its highest annual net income of $29M in fiscal 2007.
Lifecore Biomedical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PCRX ($9M net income, 1.0% margin), HALO ($317M net income, 22.7% margin), ATRC (-$5M net income, -2.1% margin), LFCR has room to improve margins relative to the peer group. Compare LFCR vs PCRX →
LFCR Earnings vs Peers
Earnings metrics vs comparable public companies
LFCR Historical Earnings Data (1996–2025)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$39M | -422.3% | -$17M | $-1.27 | -30.0% | -13.4% |
| 2024 | $12M | +112.1% | -$9M | $0.33 | 9.4% | -6.9% |
| 2023 | -$100M | +14.7% | -$22M | $-3.32 | -96.4% | -21.1% |
| 2022 | -$117M | -261.4% | -$12M | $-3.97 | -104.9% | -10.6% |
| 2021 | -$32M | +15.4% | -$9M | $-1.12 | -32.0% | -8.7% |
| 2020 | -$38M | -1899.8% | -$26M | $-1.31 | -23.9% | -16.2% |
| 2019 | $2M | -91.5% | -$8M | $0.07 | 0.4% | -1.4% |
| 2018 | $25M | +134.5% | $12M | $0.89 | 4.7% | 2.3% |
| 2017 | $11M | +191.0% | $16M | $0.38 | 2.0% | 2.9% |
| 2016 | -$12M | -185.9% | -$20M | $-0.43 | -2.2% | -3.7% |
See LFCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLFCR — Frequently Asked Questions
Quick answers to the most common questions about buying LFCR stock.
Is LFCR growing earnings?
LFCR EPS fell to $-0.91, with earnings declining -484.8%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-34M.
What are LFCR's profit margins?
Lifecore Biomedical, Inc. net margin is -30.0%, with operating margin at -13.4%. Below-average margins reflect competitive or cost pressures.
How consistent are LFCR's earnings?
LFCR earnings data spans 1996-2025. The declining earnings trend is -484.8% YoY. Historical data enables comparison across business cycles.